(CM) and Tenth Revision, respectively. Canada transitioned from ICD-9-CM to ICD-10 coding in 2002. ICD-9-CM and ICD-10 are comparable in classifying heart failure with a high degree of accuracy based on the Framingham criteria. 7, 8 From the OHIP database, we identified cases of heart failure using ICD-8 code 428. We considered a heart failure event to have occurred if there was either 1 documented admission for heart failure alone or 1 outpatient claim for heart failure that was followed by at least 1 additional outpatient heart failure claim within 1 year (i.e., the 2-claim method). We based our 2-claim ambulatory case identification method on a previously validated algorithm shown to have 84.8% sensitivity and 97.0% specificity in identifying heart failure events in the community from administrative databases (unpublished data, available on request). As a sensitivity analysis, we also conducted an analysis of a 1-claim identification method, in which 1 outpatient claim for heart failure was considered sufficient for identifying a case of heart failure. The date of hospital admission or the date of the first outpatient visit represents the date of diagnosis. We classified a case as an admission rather than an outpatient visit if both occurred on the same date. Outpatient cases include patients first identified and sent home from the emergency department.
Between Apr. 1, 1997, and Mar. 31, 2008, we identified 5 175 179 heart failure events. We excluded an event if the patient had a previous record of heart failure within 5 years before the index event. We also excluded an event if it did not represent the first instance of heart failure for a patient during the study period. We also excluded patients who were not residents of Ontario, less than 20 years old or greater than 105 years old, missing a discharge date, or reported to have a diagnosis date after a documented date of death. The remaining events constituted our cohort of incident heart failure cases.
For the subgroup analysis, we divided the cohort into 2 mutually exclusive inpatient or outpatient groups, according to where heart failure was diagnosed and care was received.
Patient characteristics
We quantified comorbid disease status using the Charlson-Deyo Comorbidity Index. [9] [10] [11] [12] A comorbid condition is coded in the secondary diagnosis field on the index discharge abstract or in the primary or secondary diagnosis fields of the discharge abstract for inpatient hospital admissions that occurred within 5 years before the index admission. The accuracy of coding of comorbidities for patients with heart failure in the CIHI Discharge Abstract Database has been validated. 7 Comorbidities among outpatients were determined by claims for these conditions that occurred within 5 years before the index outpatient visit. For both inpatient and outpatient cohorts, we also determined the prevalence of atrial fibrillation or flutter, hypertension, ischemic heart disease and valvular heart disease.
Mortality and readmission
We evaluated outcome measures including 30-day and 1-year readmission rates and mortality after the first documented event of heart failure. We determined the number of deaths from any cause using Ontario's Registered Persons Database. Only patients who were first diagnosed with heart failure in hospital and survived to discharge were eligible for the readmission analysis. We calculated separate rates for readmission for any cause and readmission for which heart failure was the most responsible diagnosis. We included only nonelective readmissions.
Statistical analysis
We standardized admission rates and outpatient visit rates by age, sex or both, and calculated the rates per 100 000 population for each fiscal year. These rates were calculated by direct standardization using the 1991 Ontario population aged 20 years or older as the reference population. Incident cases of heart failure were followed for up to 1 year. Readmission rates and mortality were reported as the number of events per 100 patients, standardized to the age-and sexdistributions within the heart failure cohort. We used previously developed and validated logistic regression models derived from similar administrative claims data in the United States to calculate annual risk-adjusted readmission and mortality rates. These models allowed us to compare temporal trends in outcomes over time, taking into account changes in the case-mix of patients with heart failure as measured using comorbidities in the administrative databases. The mortality model included 23 candidate predictors of mortality, and the readmission model included 36 candidate predictors of readmission for patients with heart failure. 13, 14 A model predictor was present if there was a claim for it in the outpatient setting or if it was coded as a main diagnosis, secondary diagnosis or preadmission comorbidity during or within 5 years before the index event. To identify statistically significant changes over time, we constructed linear regression models with the year of diagnosis as the independent variable and the crude-and riskadjusted readmission and mortality rates as the dependent variables. Only p values from these models are reported.
Results
There were 419 551 incident cases of heart failure in Ontario from 1997 to 2007, of which 216 190 patients required admission to hospital and 203 361 patients were cared for in an outpatient setting at the time of initial diagnosis (Figure 1) . Women accounted for 51% of the study population, and patients aged 65 years or older represented 80% of the overall cohort.
Compared with patients whose heart failure was diagnosed in the outpatient setting, patients admitted to hospital at the time of the initial diagnosis were older (median age 77 v. 76 yr, p < 0.001) and had more comorbidities (mean Charlson-Deyo score 2.1 v. 1.0, p < 0.001) ( Table 1) . Compared with outpatients, patients in hospital had higher rates of ischemic heart disease (inpatients 50.4%; outpatients 25.5%, p < 0.001), diabetes (inpatients 28.2%; outpatients 13.8%, p < 0.001) and hypertension (inpatients 41.8%; outpatients 23.9%, p < 0.001).
The characteristics of patients with newly diagnosed heart failure showed similar trends over time regardless of the setting in which the initial diagnosis was made. Between 1997 and 2007, the median age at diagnosis increased by 2 years among inpatients (p < 0.001) and by 1 year among outpatients (p < 0.001) ( Table 2 ). There was an increase in mean Charlson-Deyo comorbidity score from 1.9 to 2.3 among inpatients (p < 0.001) and from 1.0 to 1.1 among outpatients (p < 0.001). The prevalence of diabetes increased from 26.1% to 34.6% among inpatients (p < 0.001) and from 12.9% to 16.4% among outpatients (p < 0.001). The prevalence of hypertension similarly increased, from 35.7% to 47.2% among inpatients (p < 0.001) and from 21.5% to 25.2% among outpatients (p < 0.001). In contrast, the prevalence of ischemic heart disease decreased from 54.4% to 44.0% among inpatients (p < 0.001) and from 26.8% to 23.7% among outpatients (p < 0.001).
Trends in the incidence of heart failure
The age-and sex-standardized incidence rate of heart failure decreased by 32.7% from 454.7 per 100 000 people to 306.1 per 100 000 people (p < 0.001) during the study period ( Table 3 ). The decline in the incidence of heart failure occurred in both inpatient and outpatient settings.
The age-standardized incidence rates among men and women were not significantly different and decreased comparably throughout the study per iod (Figure 2 ). In contrast, the sex-standardized incidence of heart failure increased with age (Figure 3) . Although the sex-standardized incidence of heart failure decreased over time, the rate of decline was highest among patients aged 85 years and older. with a nonsignificant decrease of 35.7% to 33.8% among inpatients (p = 0.1)( Table 4) . Among inpatients who survived to discharge, the 1-year risk-adjusted rate of readmission for heart failure decreased from 13.4% to 10.5% (p = 0.02) and the 1-year risk-adjusted all-cause readmission rate decreased from 49.0% to 45.6% (p = 0.001).
Outcomes after diagnosis of heart failure
A sensitivity analysis of incident heart failure cases identified using a 1-outpatient-claim method as opposed to a 2-claim method showed similar declines in 1-year risk-adjusted mortality rates. The risk of incident heart failure decreased from 16.7% to 15.0% among outpatients (p = 0.004), from 35.2% to 33.1% among inpatients (p = 0.1), and from 23.1% to 20.9% among all patients (p = 0.005) (Appendix 1, available at www.cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .111958 /-/DC1). Adopting a 1-claim method had a small impact on the number of incident cases identified in the inpatient setting, and, thus, trends in readmission rates were comparable with those found using the 2-claim method.
Interpretation
We saw a 32.7% decline in the incidence of heart failure cases in Ontario between 1997 and 2007, which translates to a 3% average annual decline; this is similar to the rates of decline previously observed in overall cardiovascular disease mortality and incidence of ischemic heart disease events in Canada. 4, 15 The inclusion of outpatients is important because this group accounts for
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CMAJ, October 2, 2012, 184(14) about half of all new cases of heart failure in Ontario. Although there was a comparable and steady decline in the incidence of heart failure in both the inpatient and outpatient settings and among both men and women, the oldest age cohorts had the largest decline. Most studies about the trends associated with heart failure have reported trends in hospital admission rates and do not include ambulatory cases. Our study included ambulatory cases, and this is one of its major strengths.
In Western Europe, Australia, New Zealand and the United States, hospital admission rates for heart failure rapidly increased before the mid-1990s, prompting concern of an impending epidemic. [16] [17] [18] [19] [20] [21] However, incident and total admission rates decreased steadily thereafter. [22] [23] [24] [25] [26] [27] [28] Studies that examined population-based trends in the incidence of heart failure in the decades leading up to the 1990s showed weak correlation with hospital admission trends. [29] [30] [31] More recently, however, reductions in admissions because of heart failure appear to reflect an actual decline in the incidence of heart failure. 28, 32 Our study is the largest and most recent population-based study to address this issue and provides strong evidence that the incidence of heart failure is decreasing.
The reasons for the declining incidence of heart failure are complex and cannot be definitively determined from this study. However, we hypothesize that much of the decline is driven by a decline in the incidence of ischemic heart disease events. Ischemic heart disease is the leading cause of heart failure, and thus better primary prevention (e.g., lower smoking rates, better hypertension control, better lipid status) decreases associated complications, such as heart failure. Although improved survival after myocardial infarction might lead to more patients developing heart failure, the use of interventions that preserve ejection fraction (e.g., reperfusion therapy with primary angio- plasty) has also increased, such that there may not be a net increase in heart failure cases. 33 Hypertension is the second most important cause of heart failure and other studies have shown that Ontario has one of the highest rates of blood pressure control in recent years, which may also contribute to fewer patients with incident heart failure. 34, 35 Limitations Our study has several limitations. First, we identified cases of heart failure in the outpatient setResearch CMAJ, October 2, 2012, 184 (14) E771 ting by requiring 2 claims for heart failure within 1 year, which may have led to us to underestimate the incidence of heart failure. A separate analysis using a 1-claim method showed higher rates of heart failure in the outpatient setting, but there was no significant difference in the overall trends (Appendix 1). We prefer the 2-claim method because it improved the specificity of our case selection. In addition, compared with hospital discharge data, outpatient claims may be less reliable in identifying comorbid conditions and may have resulted in underreporting. Nevertheless, the relative prevalence rates and trends in prevalence of comorbidities over time were comparable in the inpatient and outpatient groups. Finally, because our databases lacked information on left ventricular ejection fraction, we could not comment on the severity of heart failure among patients and, in particular, whether patients had preserved or reduced ejection fractions, clinical features that have important implications for management and prognosis.
Conclusion
We found a substantial decrease in the incidence of heart failure in Ontario, which suggests that efforts to prevent heart failure over the past decade have been at least partially successful. The greatest decline in incidence occurred among the oldest cohorts, but it is the younger cohorts that will determine future trends in incidence. Although the results of our study are encouraging, the population continues to age and risk factors for heart failure such as diabetes and obesity are increasing, particularly in young people, which may cause the downward trend in incidence of heart failure to plateau or reverse. For patients with heart failure, the prognosis remains poor, with only modest improvement noted during our study period. Ongoing vigilance and research is required to ensure that prevention and treatments are optimized for all patients at risk of or who have heart failure.
